Sonic Healthcare Limited (ASX:SHL)
Australia · Delayed Price · Currency is AUD | Market Cap | 11.02B -19.1% |
| Revenue (ttm) | 10.42B +11.7% |
| Net Income | 539.40M -1.1% |
| EPS | 1.11 -2.7% |
| Shares Out | 494.08M |
| PE Ratio | 20.17 |
| Forward PE | 17.84 |
| Dividend | 1.07 (4.73%) |
| Ex-Dividend Date | Mar 4, 2026 |
| Volume | 1,834,290 |
| Open | 22.42 |
| Previous Close | 22.60 |
| Day's Range | 22.12 - 22.60 |
| 52-Week Range | 18.26 - 29.24 |
| Beta | 0.59 |
| Analysts | Hold |
| Price Target | 23.36 (+4.75%) |
| Earnings Date | Aug 18, 2026 |
About Sonic Healthcare
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ... [Read more]
Financial Performance
In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for SHL stock is "Hold." The 12-month stock price target is $23.36, which is an increase of 4.75% from the latest price.
News
Sonic Healthcare Earnings Call Transcript: H1 2026
Revenue grew 5% organically in H1 FY2026, with EBITDA margin up 30 bps and net profit at AUD 262 million. Guidance for FY2026 EBITDA is reaffirmed, with margin expansion in Germany and Switzerland, and ongoing cost control and capital management initiatives.
Sonic Healthcare Quarterly report: H1 2026
Sonic Healthcare has published its H1 2026 quarterly earnings report on February 18, 2026.
Sonic Healthcare Slides: H1 2026
Sonic Healthcare has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
Sonic Healthcare Earnings release: H1 2026
Sonic Healthcare released its H1 2026 earnings on February 18, 2026, summarizing the period's financial results.
Sonic Healthcare Transcript: AGM 2025
The meeting marked a major leadership transition, reviewed strong financial growth, and reaffirmed strategic focus on organic expansion, acquisitions, and sustainability. Shareholders approved all resolutions and discussed challenges such as regulatory risk, labor costs, and earnings growth.
Sonic Healthcare Slides: FY 2025
Sonic Healthcare has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.
Sonic Healthcare Earnings Call Transcript: H2 2025
Revenue and EBITDA both grew 8% year-over-year, with strong cash generation and margin expansion. FY 2026 guidance anticipates up to 19% EPS growth, driven by organic growth and recent acquisitions, while integration and synergy capture are underway across key geographies.
Sonic Healthcare Annual report: H2 2025
Sonic Healthcare has published its H2 2025 annual report on August 20, 2025.
Sonic Healthcare Annual report: H2 2025
Sonic Healthcare has published its H2 2025 annual report on August 20, 2025.
Sonic Healthcare Slides: H2 2025
Sonic Healthcare has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 20, 2025.
Sonic Healthcare Earnings release: H2 2025
Sonic Healthcare released its H2 2025 earnings on August 20, 2025, summarizing the period's financial results.
Sonic Healthcare initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Davin Thillainathan initiated coverage of Sonic Healthcare (SKHHY) with a Buy rating and A$32.20 price target While funding reforms in Germany are a headwind to the company’s…
Sonic Healthcare initiated with an Equal Weight at Morgan Stanley
Morgan Stanley initiated coverage of Sonic Healthcare (SKHHY) with an Equal Weight rating and A$28.10 price target Modest EPS growth has been impacted by declining margins and the company’s return…
M&A News: Sonic Healthcare Boosts German Presence with LADR Acquisition
ASX-listed Sonic Healthcare Limited ($AU:SHL) has announced the acquisition of Germany-based laboratory group LADR for an enterprise value of €423 million, bolstering its presence in the German health...
Sonic Healthcare Shares Gain on Upbeat Outlook
Shares of ASX-listed Sonic Healthcare Limited ($AU:SHL) gained 7% as of writing after the company shared an upbeat outlook for its revenue growth in an investor update at its 2024…
Sonic Healthcare upgraded to Buy from Neutral at Citi
Citi analyst Mathieu Chevrier upgraded Sonic Healthcare to Buy from Neutral with a price target of A$36, up from A$34.50. The analyst believes the company’s earnings risk is to the…